Farxiga: Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Farxiga is a medication used in the treatment of type 2 diabetes mellitus. It is available in the form of oral tablets and works by increasing the elimination of glucose through the urine. The active ingredient in Farxiga is dapagliflozin, which belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. In this article, we will explore the uses, dosage, demographic, side effects, interactions, and generic options of Farxiga. Uses Farxiga is used to lower the blood glucose levels in patients with type 2 diabetes mellitus. It is not recommended for the treatment of type 1 diabetes or diabetic ketoacidosis. The medication works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. Farxiga can be used alone or in combination with other medications such as metformin, insulin, or sulfonylureas. Dosage The recommended initial dose of Farxiga is 5 mg once daily. The dose may be increased to 10 mg once daily depending on the patient's response and tolerability. Farxiga should be taken with or without food, and the tablet should be swallowed whole with water. It is important to ensure adequate hydration while taking Farxiga. In patients with renal impairment, dose adjustment may be necessary. Demographic Farxiga is approved for the treatment of type 2 diabetes mellitus in adults. It is not recommended for use in children or adolescents. The medication is not recommended for use in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment, or end-stage renal disease. Pregnant and breastfeeding women should consult their healthcare provider before taking Farxiga. Side Effects The most common side effects of Farxiga include genital mycotic infections, urinary tract infections, and increased urination. Other side effects may include hypoglycemia, dehydration, dizziness, nausea, and fatigue. Rare but serious side effects may include hypersensitivity reactions, ketoacidosis, and acute kidney injury. Patients should inform their healthcare provider if they experience any side effects while taking Farxiga. Interactions Farxiga may interact with other medications, including insulin and sulfonylureas, which may increase the risk of hypoglycemia. It is important to inform the healthcare provider of all medications, including over-the-counter medications and herbal supplements, before starting Farxiga. Patients should also avoid consuming alcohol while taking Farxiga due to the increased risk of dehydration. Generic Options Dapagliflozin is the generic name for Farxiga. Other SGLT2 inhibitors available in the market include canagliflozin, empagliflozin, and ertugliflozin. These generic options may be more affordable compared to Farxiga, but patients should always consult their healthcare provider before switching medications. Conclusion Farxiga is a medication used in the treatment of type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. The medication is not recommended for use in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment, or end-stage renal disease. Patients should inform their healthcare provider if they experience any side effects while taking Farxiga. Dapagliflozin is the generic name for Farxiga, but patients should always consult their healthcare provider before switching medications.